The info from TCCC and Defense Health Board supports use in regard to ICP concerns:
"Ketamine has traditionally been contraindicated in patients with headinjury due to a belief that it
may increase intracranial pressure (ICP).
38
The FDA approved package insert also notes that an increase in intracranial cerebrospinal fluid pressure has been reported after administration of ketamine and advises extreme caution when using ketamine in patients with increased ICP.
35
In vitro and animal studies suggest that ketamine may in fact have neuroprotective properties due to it being an N-methyl-D-aspartate antagonist.
38, 39, 40, 41
Additionally, recent studies suggest thatketamine may be safe for brain injured patients.
38, 42, 43, 44, 45
However, these studies had small sample sizes and primarily examined ketamine administration in combination with other anesthetics or sedatives. Because many of these ketamine studies are limited to procedural sedation in pediatric populations and none address ketamine use in pre-hospital, austere environments, the generalizability to tactical settings is limited. The consensus opinion of the Board members who are subject matter experts in neurosurgery and neurotrauma reaffirmed that the quality of the studies suggesting that ketamine can be used safely in those with head injury is insufficient and that these results are not generalizable to casualties with head injuries. The DHB concludes that this literature contains low-level evidence that may not be applicable, and recommends that until large randomized controlled trials examining the use of ketamine alone demonstrate that ketamine does not increase ICP, ketamine should not be used in patients with significant TBI (penetrating brain injury or head injury with altered level of consciousness)."